Recursion Pharmaceuticals (RXRX) Property, Plant & Equipment (Net) (2020 - 2026)
Recursion Pharmaceuticals (RXRX) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 31.48 Mn |
| 10 | Recursion Pharmaceuticals | 1.57 Bn | 912.05 Mn | -6.02 Mn | 95.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.81 Mn |
| Mar 31, 2026 | 95.81 Mn |
| Dec 31, 2025 | 103.93 Mn |
| Dec 31, 2025 | 103.93 Mn |
| Sep 30, 2025 | 111.71 Mn |
| Sep 30, 2025 | 111.71 Mn |
| Jun 30, 2025 | 120.04 Mn |
| Jun 30, 2025 | 120.04 Mn |
| Mar 31, 2025 | 126.83 Mn |
| Mar 31, 2025 | 126.83 Mn |
| Dec 31, 2024 | 141.06 Mn |
| Dec 31, 2024 | 141.06 Mn |
| Sep 30, 2024 | 84.41 Mn |
| Sep 30, 2024 | 84.41 Mn |
| Jun 30, 2024 | 83.63 Mn |
| Jun 30, 2024 | 83.63 Mn |
| Mar 31, 2024 | 86.72 Mn |
| Mar 31, 2024 | 86.72 Mn |
| Dec 31, 2023 | 86.51 Mn |
| Dec 31, 2023 | 86.51 Mn |